Published in BMJ on April 26, 1997
Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007. Clin Infect Dis (2009) 2.50
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog (2010) 1.63
Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. AIDS (2012) 1.29
Lack of evidence for changing virulence of HIV-1 in North America. PLoS One (2008) 1.11
Increasing clinical virulence in two decades of the Italian HIV epidemic. PLoS Pathog (2009) 1.10
The contribution of viral genotype to plasma viral set-point in HIV infection. PLoS Pathog (2014) 0.97
Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan. J Virol (2012) 0.88
Is the clinical course of HIV infection changing? Study's censoring strategy may be source of bias. BMJ (1997) 0.83
Is the clinical course of HIV infection changing? Exclusion of people not followed up for 12 months may have biased results. BMJ (1997) 0.75
Is the clinical course of HIV infection changing? Finding is disheartening. BMJ (1997) 0.75
No HIV-1 transmission through lesbian sex. Lancet (1994) 1.56
Growth of Yersinia species in artificially contaminated blood bags. Transfusion (1992) 1.39
Candida albicans biotypes in human immunodeficiency virus type 1-infected patients with oral candidiasis before and after antifungal therapy. J Clin Microbiol (1991) 1.29
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS (1994) 1.29
Cytokine network and acute primary HIV-1 infection. AIDS (1993) 1.28
Risk of developing AIDS after primary acute HIV-1 infection. J Acquir Immune Defic Syndr (1993) 1.23
Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting. Antimicrob Agents Chemother (2005) 1.09
Asymptomatic women at high risk of vertical HIV-1 transmission to their fetuses. Br J Obstet Gynaecol (1993) 1.07
Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol (1996) 1.07
Characterisation of an antibody coated microcantilever as a potential immuno-based biosensor. Biosens Bioelectron (2002) 1.02
Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection. AIDS (1999) 1.02
Seroprevalence, risk factors and attitude to HIV-1 in a representative sample of lesbians in Turin. Genitourin Med (1994) 1.00
Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus: no evidence of faster progression to AIDS. Scand J Infect Dis (1997) 0.97
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Oncogene (2007) 0.96
Anthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study. Int J Obes Relat Metab Disord (1994) 0.96
Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med (1990) 0.95
Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect (2002) 0.95
Purification and chemical and biological characterizations of seven toxins from the Mexican scorpion, Centruroides suffusus suffusus. J Biol Chem (1987) 0.93
High serum level of soluble CD30 in acute primary HIV-1 infection. Clin Exp Immunol (1997) 0.89
Acute HIV-1 infection: clinical and biological study of 12 patients. J Acquir Immune Defic Syndr (1990) 0.89
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon. J Antimicrob Chemother (2008) 0.88
Electron microscope study of a case of Australia antigen-positive chronic hepatitis. J Clin Pathol (1973) 0.87
Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. Curr Microbiol (2000) 0.86
Meningoencephalitis caused by Toxoplasma gondii diagnosed by isolation from cerebrospinal fluid in an HIV-positive patient. Scand J Infect Dis (1993) 0.85
Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazole. Mycoses (1997) 0.84
Mechanical and electrophysiological properties of the sarcolemma of muscle fibers in two murine models of muscle dystrophy: col6a1-/- and mdx. J Biomed Biotechnol (2010) 0.83
Adenosine and the nervous system: pharmacological data and therapeutic perspectives. Gen Pharmacol (1998) 0.83
Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia. Thorax (1996) 0.82
Magnetic resonance cholangiopancreatography in the evaluation of pancreatic duct pathology. Br J Radiol (1998) 0.82
Primary HIV infection presenting with acute pancreatitis. Scand J Infect Dis (1999) 0.82
Amino acid sequence of toxin VII, a beta-toxin from the venom of the scorpion Tityus serrulatus. Biochem Biophys Res Commun (1984) 0.82
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients. J Antimicrob Chemother (2005) 0.82
Microbiological investigations on a nosocomial case of Legionella pneumophila pneumonia associated with water birth and review of neonatal cases. Infez Med (2004) 0.82
Adenosine and neuropathic pain. Pain (1996) 0.82
Lesbian sex and risk of HIV transmission. AIDS (1998) 0.81
High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates. Aliment Pharmacol Ther (2012) 0.81
Evidence for the existence of procolipase in chicken pancreas and pancreatic juice. Biochimie (1984) 0.81
Unusual eruption of cutaneous metastases from occult gastric carcinoma shortly after HIV-1 infection. Cutis (1993) 0.81
Rapid diagnosis of malaria by use of fluorescent probes. Diagn Microbiol Infect Dis (1994) 0.80
Phytosterol compounds having antiviral efficacy. Panminerva Med (1997) 0.80
Endemicity of Legionella pneumophila serogroup 3 in a hospital water supply. J Hosp Infect (1989) 0.80
Adenosine and hemodialysis in humans. J Investig Med (2001) 0.79
Growth of Candida albicans in a minimal synthetic medium without biotin. Mycopathologia (1987) 0.79
Effect of different substrata on rhizome growth, leaf biometry and shoot density of Posidonia oceanica. Mar Environ Res (2013) 0.79
Legionella taurinensis, a new species of Legionella isolated in Turin, Italy. Int J Syst Evol Microbiol (2000) 0.79
Use of HPLC to measure circulating adenosine levels in migrainous patients. Clin Chim Acta (1994) 0.79
Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection. Eur J Endocrinol (1995) 0.78
Use of parvalbumin as a protecting protein in the sequenator: an easy and efficient way for sequencing small amounts of peptides. FEBS Lett (1976) 0.78
The use of HPLC to evaluate the variations of blood coronary adenosine levels during percutaneous transluminal angioplasty. Clin Chim Acta (1994) 0.78
Effect of erythromycin on the immune response and interferon production. Immunopharmacology (1988) 0.78
Is a 3-month course of treatment with Peg-interferon effective in acute HCV hepatitis? J Biol Regul Homeost Agents (2003) 0.78
Relapse of Toxoplasma encephalitis and susceptibility to pyrimethamine: lack of evidence of treatment-induced resistance. Antimicrob Agents Chemother (1995) 0.78
Effects of long-term zidovudine treatment on cell-mediated immune response and lymphokine production. J Acquir Immune Defic Syndr (1991) 0.77
Multiwell micromechanical cantilever array reader for biotechnology. Rev Sci Instrum (2007) 0.77
Adenosine and migraine. Can J Neurol Sci (1998) 0.77
Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infection. AIDS (2000) 0.77
Interactions between cyclosporine A and adenosine in kidney transplant recipients. Kidney Int (1998) 0.77
Purification of six neurotoxins from the venom of Dendroaspis viridis. Primary structure of two long toxins. Eur J Biochem (1976) 0.77
Adsorption of trimethoxysilane and of 3-mercaptopropyltrimethoxysilane on silica and on silicon wafers from vapor phase: an IR study. Langmuir (2007) 0.77
Pulmonary sarcoidosis associated with Leydig cell testicular neoplasm. Chest (1988) 0.77
Relationship between circulating immune complexes, serum interferon and clinical features in sarcoidosis. Respiration (1985) 0.76
The influence of cytomegalovirus on the natural history of HIV infection: evidence of rapid course of HIV infection in HIV-positive patients infected with cytomegalovirus. Scand J Infect Dis (1997) 0.76
Interdependence of initial cell density, drug concentration and exposure time revealed by real-time impedance spectroscopic cytotoxicity assay. Analyst (2015) 0.76
Immunochemistry of scorpion alpha-neurotoxins. Determination of the antigenic site number and isolation of a highly enriched antibody specific to a single antigenic site of toxin II of Androctonus australis Hector. Mol Immunol (1983) 0.76
Imipenem/cilastatin as empirical treatment of severe infections in compromised patients. J Chemother (1991) 0.76
Adenosine and the nervous system: clinical implications. Clin Neuropharmacol (1996) 0.75
Determinants of HIV disease progression. Lancet (1992) 0.75
Vulvodynia and HIV: causal or casual association? Genitourin Med (1997) 0.75
Prognostic significance of soluble CD8 serum levels in HIV-1 infection. AIDS (1992) 0.75
Statins alter oxidant-antioxidant status and lower exercise-induced oxidative stress. Int J Clin Pharmacol Ther (2007) 0.75
[Description of a case of aneurysm of the intrahepatic portal vein]. Radiol Med (1992) 0.75
[Psychological reactions of medical staff to the patients infected with HIV-1]. Minerva Psichiatr (1993) 0.75
[The hemodynamic significance of the angiographic changes after portasystemic shunting interventions for portal hypertension]. Radiol Med (1992) 0.75
Occlusion of the descending aorta: effects on some parameters of the left ventricle cycle. Boll Soc Ital Biol Sper (1986) 0.75
[Extra-neurological clinical use of magnetic resonance]. Radiol Med (1987) 0.75
Susceptibility to ketoconazole of Candida albicans strains from sequentially followed HIV-1 patients with recurrent oral candidosis. Mycoses (1992) 0.75
Esophagogastroplasty and its radiological approach. Diagn Imaging Clin Med (1985) 0.75
[Acute necrotizing ulcerative gingivitis (ANUG) in HIV antibody-positive subjects]. Minerva Stomatol (1991) 0.75
Endoscopy to detect oral and oesophageal candidiasis in acquired immune deficiency syndrome. Ital J Gastroenterol (1992) 0.75
Circulating acid-labile interferon in chronic versus acute, HBV-related liver disease. A marker of immune-mediated hepatocellular damage? Boll Ist Sieroter Milan (1985) 0.75
[Pure and diluted contrast media in the visualization of the portal venous system using digital angiography]. Radiol Med (1990) 0.75
[Use of echography for the diagnosis of joint amyloidosis in dialyzed patients]. J Radiol (1991) 0.75